GelStat Corp.

GelStat Corp.

OOTC:GSAC
0.00
USD
0.00
(0.00%)
-0.02EPS
1.07MMarket Cap
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
TTM
Revenue per Share
1.83
0.86
0.72
0.48
0.02
- -
- -
- -
0.02
0.02
0.01
- -
- -
- -
Basic EPS, GAAP
-0.06
0.18
-0.08
-0.81
-0.25
-0.03
0.33
-0.22
-0.56
-0.41
-0.1
-0.04
-0.02
-0.02
Free Cash Flow per Basic Share
-0.3
0.05
-0.08
0.08
-0.1
-0.04
-0.08
-0.19
-0.52
-0.14
-0.03
-0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.37
0.42
0.87
0.17
-0.02
-0.06
-0.04
0.12
0.1
-0.08
-0.07
-0.08
-0.06
-0.06
Tangible Book Value per Share
0.37
0.42
0.87
0.17
-0.02
-0.06
-0.04
0.11
0.09
-0.08
-0.07
-0.08
-0.06
-0.06
Basic Weighted Avg Shares
3
4
2
2
3
4
4
7
11
14
18
25
31
31
Sales/Revenue/Turnover
5
3
2
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
3.93
15.99
-0.14
-5.44
-864.44
-6,329.65
- -
- -
-2,398.02
-1,099.24
-752.7
-5,722.42
-1,815.11
-1,815.04
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
1
- -
-2
-1
- -
1
-1
-6
-6
-2
-1
- -
- -
Effective Tax Rate (%)
53.62
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-3.41
21.46
-10.65
-170.47
-1,426.15
-3,835.62
- -
- -
-2,541.55
-1,713.42
-776.94
-5,960.31
-2,011.73
-2,011.64
Working Capital
1
1
1
- -
- -
- -
- -
1
1
-1
-2
-2
-2
-2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
1
2
2
- -
- -
- -
- -
1
1
-1
-2
-2
-2
-2
Return on Invested Capital (%)
- -
36.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
43
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
55.64
-9.98
-151.81
- -
- -
- -
- -
-591.14
- -
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Jun'08
Sep'08
Dec'08
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
34
36
Market Capitalization
1
1
1

Working Capital

USD

•

in mil. unless spec.
Jun'08
Sep'08
Dec'08
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
2
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-77.03%
-22.6%
11.11%
Free Cash Flow
2.27%
18.28%
-47.82%
Net Income, GAAP
-59.73%
29.85%
-57.26%
Sales/Revenue/Turnover
- -
- -
26.63%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
-0.04
-0.02
-0.02
-0.02
-0.1
2007
-0.01
-0.01
-0.01
-0.01
-0.04
2008
-0.01
-0.01
- -
- -
-0.02

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

CEO
Javier G. Acosta
Full Time Employees
2
Sector
Health technology
Industry
Pharmaceuticals: other
Address
333 SE 2nd Avenue Miami FL United States 33131
IPO Date
Apr 23, 1993
Business
GelStat Corporation (OTC: GSAC) develops and markets innovative gel-based nutritional and wellness products targeting digestive health, pain relief, and sleep support. The company offers GelTabs, a proprietary delivery system utilizing advanced gel matrix technology for rapid absorption; core products include Lidtke GelStat Migraine Relief for fast-acting migraine symptom alleviation, GelStat Migraine but without caffeine, GelStat Sleep for natural sleep aid, and GelStat Ultra Pain Relief for joint and muscle discomfort. These products are distributed through retail channels, e-commerce platforms, and healthcare providers in the United States. Founded in 2002 and headquartered in Duluth, Georgia, GelStat operates primarily in the consumer health and nutraceuticals segment, serving individual consumers seeking non-pharmaceutical alternatives. In recent developments, the company has focused on expanding its product pipeline and distribution partnerships within the last two years, including enhanced marketing alliances with major retailers to broaden accessibility of its GelTabs line.

Company News

  • GSAC Engineering Secures Multi-Year Recurring Revenue Contract

  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group